Lisata Therapeutics(LSTA) - 2024 Q2 - Quarterly Results

Exhibit 99.1 Lisata Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update Phase 2b ASCEND trial top-line data remains on track to be reported in fourth quarter of 2024 Available cash projected to fund current operations into early 2026 and all active studies through to data Conference call scheduled for today at 4:30 p.m. Eastern Time BASKING RIDGE, NJ (August 12, 2024) – Lisata Therapeutics, Inc. (Nasdaq: LSTA) ("Lisata" or the "Company"), a clinical-stage pharmaceutical c ...